Replacing Cys5 by Pen (penicillamine, b,b-dimethylcysteine) in the cyclic C-terminal U-II octapeptide, U-II(4-11), we have obtained a potent urotensin II (U-II) receptor agonist. Conformational analysis of solution NMR data indicated that the putative biologically active conformation of U-II is stabilized by introduction of a Pen residue. To the best of our knowledge, this is the most potent U-II receptor agonist reported to date.
A new potent urotensin II receptor peptide agonist containing a Pen residue at disulfide bridge / P. GRIECO; A. CAROTENUTO;P. CAMPIGLIA; E. ZAMPELLI; R. PATACCHINI; C. MAGGI; E. NOVELLINO; P. ROVERO. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - STAMPA. - 45:(2002), pp. 4391-4394. [10.1021/jm025549i]
A new potent urotensin II receptor peptide agonist containing a Pen residue at disulfide bridge.
ROVERO, PAOLO
2002
Abstract
Replacing Cys5 by Pen (penicillamine, b,b-dimethylcysteine) in the cyclic C-terminal U-II octapeptide, U-II(4-11), we have obtained a potent urotensin II (U-II) receptor agonist. Conformational analysis of solution NMR data indicated that the putative biologically active conformation of U-II is stabilized by introduction of a Pen residue. To the best of our knowledge, this is the most potent U-II receptor agonist reported to date.File | Dimensione | Formato | |
---|---|---|---|
Grieco-JMC-2002.pdf
Accesso chiuso
Tipologia:
Versione finale referata (Postprint, Accepted manuscript)
Licenza:
Tutti i diritti riservati
Dimensione
124.54 kB
Formato
Adobe PDF
|
124.54 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.